Chunping Liu1,2†
Jian-Xing Liu1†Jiangyong Gu3Fang Liu4
Jin Hua Li1Bin Yang5Yuan Zheng1Jie Li1
Shou-Hai Wu1
Qing-He Wu1Xian Zhang1
Long-Mei Li1
Hai-Long Yang1
Lei Wang1*
Xiong Li1*- 1The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
- 2Dongguan and Guangzhou University of Chinese Medicine Cooperative Academy of Mathematical Engineering for Chinese Medicine, Dongguan, China
- 3Research Center of Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, China
- 4Institute of Tropical Medicine, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China
- 5Guangzhou Medical University School of Basic Medicine, Guangzhou, China
by Liu C, Liu J-X, Gu J, Liu F, Li J, Yang B, Zheng Y, Li J, Wu S-H, Wu Q-H, Zhang X, Li L-M, Yang H-L, Wang L and Li X (2021). Front. Pharmacol. 11:580064. doi: 10.3389/fphar.2020.580064
In the published article, there was an error in Figures 7B, C as published. The p38 strips in Figures 7B, C is a duplicate, which was incorrectly pasted during data processing.
Figure 7. Effects of C, R, I (1, 2, 3) on p38 MAPK, ERK, and JNK activation in RAW264.7 cells stimulated by LPS. Pretreatment with; (A) C; (B) R; (C) I; Values are indicated as the mean of four mice per group. *p < 0.05, **p < 0.01 as compared to the LPS group, #p < 0.05, ##p < 0.01 as compared to the normal control group. Combined effect of C + R + I on inhibiting the activation of MAPK-NF-κB signaling pathway.
The corrected Figures 7B, C and its caption Effects of C, R, I (1, 2, 3) on p38 MAPK, ERK, and JNK activation in RAW264.7 cells stimulated by LPS appear below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Sarcandra glabra, chlorogenic acid, rosmarinic acid, isofraxidin, acute lung injury, MAPK-NF-kB
Citation: Liu C, Liu J-X, Gu J, Liu F, Li JH, Yang B, Zheng Y, Li J, Wu S-H, Wu Q-H, Zhang X, Li L-M, Yang H-L, Wang L and Li X (2024) Corrigendum: Combination effect of three main constituents from Sarcandra glabra inhibits oxidative stress in the mice following acute lung injury: a role of MAPK-NF-κB pathway. Front. Pharmacol. 14:1335005. doi: 10.3389/fphar.2023.1335005
Received: 08 November 2023; Accepted: 28 December 2023;
Published: 21 March 2024.
Edited and reviewed by:
Vincent Kam Wai Wong, Macau University of Science and Technology, Macao SAR, ChinaCopyright © 2024 Liu, Liu, Gu, Liu, Li, Yang, Zheng, Li, Wu, Wu, Zhang, Li, Yang, Wang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiong Li, mantianxing1997@126.com; Lei Wang, Dr.wanglei@139.com
†These authors have contributed equally to this work